⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 30 in last 7 days 🍎 Food: 2 in last 7 days 🧸 Products: 0 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 1 hour ago ⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 30 in last 7 days 🍎 Food: 2 in last 7 days 🧸 Products: 0 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 1 hour ago
🛡️ EUSW
💊 Medicines 🍎 Food 🧸 Products 🔎 Search
📊 Data
🏷 Brands 🌍 Countries ℹ️ About ✉ Unsubscribe
🇬🇧
🇬🇧 English 🇳🇱 Nederlands 🇫🇷 Français 🇩🇪 Deutsch 🇪🇸 Español 🇮🇹 Italiano 🇵🇹 Português 🇵🇱 Polski 🇸🇪 Svenska 🇷🇴 Română 🇨🇿 Čeština 🇫🇮 Suomi 🇩🇰 Dansk
💊 Medicine AT August 14, 2026

Neurontin 400 mg - Hartkapseln 400 mg (Hartkapsel)

📷 Wikipedia: Gabapentin · Source
Neurontin 400 mg - Hartkapseln 400 mg (Hartkapsel)
📷 Wikipedia: Gabapentin · Source
Neurotin 400 mg hard capsules are banned from parallel export. Supply is delayed. Affected packs: 100 capsules in blister strips, unavailable since 7 August 2026, next delivery 25 September 2026.
✅
Resolved by agency
The issuing agency has confirmed this medicine alert is over — the underlying issue was addressed. Originally reported 28 days ago.
📈 Timeline
13 days in total
August 15, 2026 August 28, 2026

What is this? Neurontin 400 mg is a medicine with the active ingredient gabapentin. It is used to treat nerve pain or seizures.

What's happening? There is a delay in getting new supplies of this medicine. The packs are not available right now.

Does this affect me? If you take gabapentin 400 mg in Austria, this shortage may affect you.

What should I do? Ask your pharmacist or doctor for advice before changing your medicine.

🤖 This plain-language summary is automatically generated from the official agency notice using AI. It is for general information only — not medical advice. For decisions about your health, always consult a pharmacist or doctor and read the official source linked below.

🔬 Medical / technical details (for professionals)
Active substance(s)
GABAPENTIN
Agency-published detail

🚫 Parallel export ban active · ATC: N02BF01 · Reason: Verzögerung bei der Auslieferung · Marketing authorisation holder: Viatris Healthcare Limited, Damastown Road Damastown Industrial Park -, D15 XD71 Dublin 15, Irland · Affected packs: 100 Stück Schachtel, Blisterpackung [Nicht verfügbar, since 2026-08-07, resupply 2026-09-25]

First published
August 14, 2026
Last refreshed by us
1 week ago
Severity (as classified)
Low
Official source
https://medikamente.basg.gv.at/en/medicine-shortage

All information on this page comes from the official agency notice. We translate and summarise it; we don't add or edit facts.

Related alerts

Medium AT resolved 3 months ago

Gabapentin ratiopharm 800 mg - Filmtabletten 800 mg (Filmtablette)

Gabapentin ratiopharm 800 mg film-coated tablets are subject to a parallel export ban.

❓ Frequently asked questions

▸ What is this medicine shortage alert about?
Neurontin 400 mg - Hartkapseln 400 mg (Hartkapsel). Neurotin 400 mg hard capsules are banned from parallel export. Supply is delayed. Affected packs: 100 capsules in blister strips, unavailable since 7 August 2026, next delivery 25 September 2026.
▸ When was this alert issued?
This alert was issued on August 14, 2026 by BASG (Austria).
▸ Which countries are affected?
The alert applies to Austria.
▸ How serious is this alert?
Low risk. A low risk means harm is unlikely under normal use. The alert is informational but still worth reading.
▸ What should I do?
If you take this medicine, contact your pharmacist or prescribing doctor. They can advise on alternative products or substitutes. Do not stop taking prescription medicine without medical advice.
▸ Where can I find the official notice?
The full official notice is published on medikamente.basg.gv.at.

💬 Discussion

Share your experience or ask a question. Real names and email are optional but moderation friendly.

No comments yet — be the first.

We email a confirmation link. Your address stays private.

⚠️ We aggregate official notices. We do not give medical advice. For medical or legal decisions, consult the source agency and a qualified professional.